Correlation Analysis between Idiopathic Pulmonary Fibrosis and Tumor Markers

Ajani J A, Jinghong Zhang

Abstract


The purpose of this study was to investigate the correlation between idiopathic pulmonary fibrosis (IPF) and tumor markers to provide evidence for early screening of precancerous lesions. In our hospital from July 2017 to May 2019, 40 patients with IPF treatment were selected as the IPF group, and 40 patients with idiopathic pulmonary fibrosis with lung cancer (IPF-LC)were selected as the IPF-LC group. In the same period, 40 healthy physical examinees were used as control group. Different types ofpatients in the IPF-LC group were divided into lung adenocarcinoma group, small cell lung cancer group and l squamous carcinoma group. The expression levels of tumor markers were detected in the three groups, the positive rates of tumor markers in IPF group,IPF-LC group and their subgroups were compared. The results showed that the levels of neuron specific enolase (NSE), antigen CYFRA211, carcinogenic antigen (CEA) and cancer antigen 125 (CA125) in IPF and IPF-LC groups were significantly higher than those in control group (P<0.05). There was no significant difference in CEA and CYFRA211 between IPF-LC group and IPF group. The level of NSE in IPF-LC group was significantly higher than that in IPF group, while the level of CA125 was significantly lower than that in IPF group (P < 0.0. 5). The difference of positive rate of NES and CA125 in IPF-LC group and IFP group was statistically significant (P< 0.05), there was no statistically significant difference in the positive rate of other indicators (P>0.05) The NSE positive rate of IPF group was significantly lower than that of IPF-LC group (P<0.05), the positive rates of other tumor markers were significantly lower than those of each subgroup of IPF-LC group (P<0.05). Therefore, tumor markers in IPF patients showed different degrees of increase, which is worthy of clinical attention. Among them, NSE can be used as an early screening indicator for IPF precancerous lesions.

Keywords


Idiopathic pulmonary fibrosis; Tumor markers; Correlation

Full Text:

PDF

References


Zhang HJ, Gu X, Liu W, et al. Analysis of tumor markers in patients with idiopathic pulmonary interstitial fibrosis [J]. Chinese journal of lung diseases (electronic edition), 2016,9 (6):621-624.

Du RJ. Correlation analysis and clinical observation between tumor markers and pulmonary interstitial fibrosis [D]. Dalian: Dalian Medical University, 2016.

Sun QR, Weng BQ, Cao H. Relationship between serum tumor markers and disease severity in patients with idiopathic pulmonary fibrosis [J]. Modern instruments and medicine, 2017,23 (3):84-86.

Liu JS, Chen X, Gao HM, et al. Clinical study on the correlation between tumor markers and idiopathic pulmonary interstitial fibrosis [J]. Chinese journal of modern medicine, 2016,26 (8):51-55.

Gan LP, Li SY, Lin X, et al. Tumor markers and idiopathic lung An analysis of the correlation between the severity of fibrosis [J]. Journal of applied medicine, 2013,29 (20):3333-3335.

Zhao J. Clinical significance of serum CEA, CYFRA21-1 and NSE detection in idiopathic pulmonary interstitial fibrosis complicated with IPF-LC [D]. Jinan: University of Jinan, 2014.

Raghu G,Collard HR,Egan JJ,et al. ATS/ERS/JRS/ALAT committee on idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. American journal of respiratory &critical care medicine,2011,183(6):788-824.

Liu JS, Chen X, Gao HM, et al. Clinical study on the correlation between tumor markers and idiopathic pulmonary interstitial fibrosis [J]. Chinese journal of modern medicine, 2016,26 (8):51-55.

Zhao J. Clinical significance of serum CEA, CYFRA21-1 and NSE detection in idiopathic pulmonary interstitial fibrosis complicated with IPF-LC [D]. Jinan: University of Jinan, 2014.

Deng YT, Lu XD, Pang LJ, et al. Screening of risk factors for acute exacerbation of idiopathic pulmonary interstitial fibrosis [J]. Journal of liaoning university of traditional Chinese medicine, 2019,21 (7):93-96.

Zhang XY. progress in the pathogenesis of idiopathic pulmonary interstitial fibrosis [J]. Journal of applied medicine, 2017,34 (1):72-75; 79.




DOI: http://dx.doi.org/10.30564/amor.v5i3.245

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Ajani J A, Jinghong Zhang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.